ESTIMATING THE POTENTIAL BUDGET IMPACT OF ZELBORAF (VEMURAFENIB) FOR ADVANCED MELANOMA TREATMENT IN BRAZILIAN PRIVATE HEALTH CARE SYSTEM

被引：0
|
作者：
Tsuchiya, C. T. [1 ]
Buschinelli, C. T. [1 ]
Maximo, M. F. M. [1 ]
Tobaruella, F. S. [1 ]
Borges, L. G. [1 ]
机构：
[1] Roche Brazil, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.641
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [1] COMPARING THE POTENTIAL BUDGET IMPACT OF NOVEL THERAPIES FOR ADVANCED MELANOMA IN SECOND-LINE UNDER BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Tsuchiya, C. T.
    Buschinelli, C. T.
    Tobaruella, F. S.
    Maximo, M. F. M.
    Guzzo, M. R.
    Goncalves, T. M.
    VALUE IN HEALTH, 2013, 16 (07) : A683 - A683
  • [2] ESTIMATING THE BUDGET IMPACT OF ADDING AVASTIN (BEVACIZUMAB) TO FRONT LINE TREATMENT FOR ADVANCED OVARIAN CANCER IN BRAZILIAN SUPPLEMENTARY HEALTH CARE SYSTEM
    Tsuchiya, C. T.
    Buschinelli, C. T.
    Maximo, M. F. M.
    Tobaruella, F. S.
    Goncalves, T. M.
    VALUE IN HEALTH, 2013, 16 (07) : A400 - A400
  • [3] BUDGET IMPACT OF PNEUMOCOCCAL DISEASE: BRAZILIAN PRIVATE HEALTH CARE DATABASE ANALYSIS
    Santana, C. F.
    Ferreira, C. N.
    Squiassi, H. B.
    VALUE IN HEALTH, 2016, 19 (03) : A112 - A113
  • [4] BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF IBRUTINIB FOR THE TREATMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Paiva, H.
    Asano, E.
    VALUE IN HEALTH, 2016, 19 (03) : A143 - A143
  • [5] BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Barbosa, E.
    Ribeiro, E.
    Asano, E.
    Nita, M.
    Rached, R.
    Mantilla, P.
    Pimentel, A.
    Donato, B. M.
    Rahal, E.
    VALUE IN HEALTH, 2010, 13 (03) : A56 - A57
  • [6] ESTIMATING THE BUDGET IMPACT OF INTRODUCING INDACATEROL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS) PERSPECTIVE
    Suzuki, C.
    Silva, N. L.
    VALUE IN HEALTH, 2011, 14 (07) : A489 - A490
  • [7] THE IMPACT OF JUDICIALIZATION OF ECULIZUMAB ON THE BUDGET OF BRAZILIAN HEALTH SYSTEM
    Simabuku, E. M.
    Beutel, J. O.
    Souza, K. M.
    Biella, C. D.
    Rabelo, R. B.
    Brito, A. F.
    VALUE IN HEALTH, 2018, 21 : S250 - S250
  • [8] ESTIMATING THE BUDGET IMPACT IN BRAZILIAN PUBLIC HEALTH CARE SYSTEM OF TOCILIZUMAB REIMBURSEMENT AS A RHEUMATOID ARTHRITIS FIRST-LINE BIOLOGICAL THERAPY
    Tsuchiya, C. T.
    Tobaruella, F. S.
    Ramos, L. A.
    Buschinelli, C. T.
    Maximo, M. F. M.
    Goncalves, T. M.
    VALUE IN HEALTH, 2013, 16 (07) : A715 - A715
  • [9] COST-EFFECTIVENESS ANALYSIS OF ABIRATERONE FOR THE TREATMENT OF ADVANCED PROSTATE CANCER UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Pereira, M. L.
    Bahmdouni, L. S. K.
    Pepe, C.
    Teich, V
    VALUE IN HEALTH, 2012, 15 (07) : A424 - A425
  • [10] BUDGET IMPACT ANALYSIS OF INCORPORATING CRYOBALLON CRYOABLATION FOR TREATMENT OF ATRIAL FIBRILLATION IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Borghossian, S.
    Fujii, F. A.
    Moretti, P.
    VALUE IN HEALTH, 2020, 23 : S98 - S98
12345